These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17322532)

  • 1. Design, expression, and stability of a diverse protein library based on the human fibronectin type III domain.
    Olson CA; Roberts RW
    Protein Sci; 2007 Mar; 16(3):476-84. PubMed ID: 17322532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanical unfolding intermediates observed by single-molecule force spectroscopy in a fibronectin type III module.
    Li L; Huang HH; Badilla CL; Fernandez JM
    J Mol Biol; 2005 Jan; 345(4):817-26. PubMed ID: 15588828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdomain mobility and conformational stability of type III fibronectin domain pairs control surface adsorption, desorption and unfolding.
    Pereira P; Kelly SM; Gellert PR; van der Walle CF
    Colloids Surf B Biointerfaces; 2008 Jun; 64(1):1-9. PubMed ID: 18261887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monobodies: antibody mimics based on the scaffold of the fibronectin type III domain.
    Koide A; Koide S
    Methods Mol Biol; 2007; 352():95-109. PubMed ID: 17041261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of an arbitrary sequence in solubility.
    Ito Y; Kawama T; Urabe I; Yomo T
    J Mol Evol; 2004 Feb; 58(2):196-202. PubMed ID: 15042340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expressivity tag: a novel tool for increased expression in Escherichia coli.
    Hansted JG; Pietikäinen L; Hög F; Sperling-Petersen HU; Mortensen KK
    J Biotechnol; 2011 Sep; 155(3):275-83. PubMed ID: 21801766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of the third fibronectin type III domain of human tenascin-C through minimal mutation and rational design.
    Gilbreth RN; Chacko BM; Grinberg L; Swers JS; Baca M
    Protein Eng Des Sel; 2014 Oct; 27(10):411-8. PubMed ID: 24996411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folding and stability of a fibronectin type III domain of human tenascin.
    Clarke J; Hamill SJ; Johnson CM
    J Mol Biol; 1997 Aug; 270(5):771-8. PubMed ID: 9245604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green fluorescent protein and factorial approach: an effective partnership for screening the soluble expression of recombinant proteins in Escherichia coli.
    Coutard B; Gagnaire M; Guilhon AA; Berro M; Canaan S; Bignon C
    Protein Expr Purif; 2008 Oct; 61(2):184-90. PubMed ID: 18602837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the elasticity of fibronectin fibrils: unfolding strengths of FN-III and GFP domains measured by single molecule force spectroscopy.
    Abu-Lail NI; Ohashi T; Clark RL; Erickson HP; Zauscher S
    Matrix Biol; 2006 Apr; 25(3):175-84. PubMed ID: 16343877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence-developability mapping of affibody and fibronectin paratopes via library-scale variant characterization.
    Nielsen GH; Schmitz ZD; Hackel BJ
    Protein Eng Des Sel; 2024 Jan; 37():. PubMed ID: 38836499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing the stability and solubility of the glucocorticoid receptor ligand-binding domain by high-throughput library screening.
    Seitz T; Thoma R; Schoch GA; Stihle M; Benz J; D'Arcy B; Wiget A; Ruf A; Hennig M; Sterner R
    J Mol Biol; 2010 Nov; 403(4):562-77. PubMed ID: 20850457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fluorescent fusion proteins with 10th human fibronectin domain].
    Petrovskaia LE; Gapizov SSh; Shingarova LN; Kriukova EA; Boldyreva EF; Iakimov SA; Svirshchevskaia EV; Lukashev EP; Dolgikh DA; Kirpichnikov MP
    Bioorg Khim; 2014; 40(4):405-13. PubMed ID: 25898750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From no expression to high-level soluble expression in Escherichia coli by screening a library of the target proteins with randomized N-termini.
    Kim KH; Yang JK; Waldo GS; Terwilliger TC; Suh SW
    Methods Mol Biol; 2008; 426():187-95. PubMed ID: 18542864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of novel FN3 domains with high stability by a consensus sequence approach.
    Jacobs SA; Diem MD; Luo J; Teplyakov A; Obmolova G; Malia T; Gilliland GL; O'Neil KT
    Protein Eng Des Sel; 2012 Mar; 25(3):107-17. PubMed ID: 22240293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased folding stability of TEM-1 beta-lactamase by in vitro selection.
    Kather I; Jakob RP; Dobbek H; Schmid FX
    J Mol Biol; 2008 Oct; 383(1):238-51. PubMed ID: 18706424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid directed evolution of stabilized proteins with cellular high-throughput encapsulation solubilization and screening (CHESS).
    Yong KJ; Scott DJ
    Biotechnol Bioeng; 2015 Mar; 112(3):438-46. PubMed ID: 25220691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple dual selection for functionally active mutants of Plasmodium falciparum dihydrofolate reductase with improved solubility.
    Japrung D; Chusacultanachai S; Yuvaniyama J; Wilairat P; Yuthavong Y
    Protein Eng Des Sel; 2005 Oct; 18(10):457-64. PubMed ID: 16120637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refolding out of guanidine hydrochloride is an effective approach for high-throughput structural studies of small proteins.
    Maxwell KL; Bona D; Liu C; Arrowsmith CH; Edwards AM
    Protein Sci; 2003 Sep; 12(9):2073-80. PubMed ID: 12931005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibronectin type III domain as a scaffold for novel binding proteins.
    Koide A; Bailey CW; Huang X; Koide S
    J Mol Biol; 1998 Dec; 284(4):1141-51. PubMed ID: 9837732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.